Lee, Daniel S. W. http://orcid.org/0000-0002-4690-9012
Wingreen, Ned S. http://orcid.org/0000-0001-7384-2821
Brangwynne, Clifford P. http://orcid.org/0000-0002-1350-9960
Funding for this research was provided by:
National Science Foundation (DCE-1656466, PHY-1734030)
U.S. Department of Health & Human Services | National Institutes of Health (U01 DA040601)
Howard Hughes Medical Institute
Article History
Received: 18 May 2020
Accepted: 16 November 2020
First Online: 11 January 2021
Competing interests
: C.P.B. is a founder and consultant for Nereid Therapeutics. All other authors declare no competing interests.